[PDF] Top 20 <p>Comparison of CHOP vs CHOPE for treatment of peripheral T-cell lymphoma: a meta-analysis</p>
Has 10000 "<p>Comparison of CHOP vs CHOPE for treatment of peripheral T-cell lymphoma: a meta-analysis</p>" found on our website. Below are the top 20 most common "<p>Comparison of CHOP vs CHOPE for treatment of peripheral T-cell lymphoma: a meta-analysis</p>".
<p>Comparison of CHOP vs CHOPE for treatment of peripheral T-cell lymphoma: a meta-analysis</p>
... with CHOP and CHOPE were searched using several major databases including PubMed, Embase, Wanfang, and CNKI with the search terms “(peripheral t-cell lymphoma) AND (etoposide OR ... See full document
8
<p>Comparison of high-dose, short-course levofloxacin treatment vs conventional regimen against acute bacterial infection: meta-analysis of randomized controlled trials</p>
... This meta-analysis based on seven studies found that high- dose, short-course levo fl oxacin had a similar clinical suc- cess rate of treating acute bacterial infections to the the conventional ...this ... See full document
9
<p>Doublet vs Single-Agent Maintenance Therapy in the Treatment of Non-Small-Cell Lung Cancer: A Meta-Analysis</p>
... published meta-analyses have con fi rmed that single-agent maintenance therapy in advanced NSCLC can prolong time to disease progression and potentially increase OS in comparison to ...present ... See full document
7
R-CHOP versus R-CVP in the treatment of follicular lymphoma: a meta-analysis and critical appraisal of current literature
... follicular lymphoma, response may not be an adequate ...to treatment failure (TTF) could be more relevant and could avoid the bias of meas- ...(81% vs. 57%; P < .001), TTF (27 months ... See full document
7
Therapeutic options in peripheral T cell lymphoma
... received CHOP/CHOP-like regimens prior to enrollment (96 %), and the median number of systemic therapies was ...belinostat treatment enabled 12 patients to undergo ...discontinued treatment as ... See full document
10
<p>Prognostic analysis of CD5 expression in double-hit diffuse large B-cell lymphoma and effectiveness comparison in patients treated with dose-adjusted EPOCH plus rituximab/R-CHOP regimens</p>
... optimal treatment in CD5+ DLBCL in the era of rituximab, phy- sicians choose treatments based on DLBCL therapy ...months vs not reached, ...multivariate analysis; however, there were only two CD5+ ... See full document
11
Profile of belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma
... of lymphoma while recommending treatment. Not all subtypes of T-lymphoma have been included in the various ...of lymphoma. Subgroup analysis of these small studies may not be a ... See full document
7
<p>Gemcitabine, cisplatin, prednisone, and thalidomide for relapse and refractory peripheral T-cell lymphoma: a retrospective study from China</p>
... including CHOP, ...of treatment and female patients were prohibited ...available treatment options such as brentux- imab vedotin and so on about the ALK+ALCL, and the heterogeneity in response and ... See full document
8
Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphoma
... 80% power at an overall 5% significance level (2-sided, with an alpha level of 0.05). In Simon’s first stage, 15 patients were enrolled. If the response rate is 75% or higher, then the second stage has to enroll ... See full document
7
CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial.
... the CHOP group, although this might mainly relect the dose modiications that were required with the GEM-P regimen according to blood results on the day of ...GEM-P treatment was incorrectly ... See full document
12
<p>Arm port vs chest port: a systematic review and meta-analysis</p>
... through peripheral forearm vessels is more surgically chal- lenging, but arm port users experience less perception of “ foreign body ” , with satisfactory cosmetic ... See full document
14
<p>Clinicopathological Characteristics and Mutational Profiling of Adult T-Cell Lymphoblastic Lymphoma in a Chinese Population</p>
... A total of 43 adult patients with T-LBL were identi fi ed over a 9-year period in Guangdong Provincial People ’ s Hospital, China. Baseline characteristics are shown in Table 1. The median age of the patients was ... See full document
10
<p>Evaluating Acalabrutinib In The Treatment Of Mantle Cell Lymphoma: Design, Development, And Place In Therapy</p>
... cohort vs 25% grade 3 and 25% grade 4 neutropenia in the R/R ...cohort vs 85% (CI 62 – 97%) in the R/R ...cohort vs 13 (65% of evaluable patients) in the R/R ...cohort vs (20%) in the R/R ... See full document
12
Hypercalcemia as a rare presentation of angioimmunoblastic T cell lymphoma: a case report
... peripheral T cell lymphomas. Due to the paucity of this disease, there is still no identifiable etiology, no consist- ent risk factors, and the pathogenesis remains unclear. AITL is considered a ... See full document
5
Peripheral T cell lymphoma: clinical utility of romidepsin
... patients’ peripheral mononuclear ...of treatment with romidepsin in the third patient, and the fourth patient with peripheral T cell lymphoma was declared to be in complete ... See full document
7
<p>Hybrid graft vs autograft in anterior cruciate ligament reconstruction: a meta-analysis</p>
... The literature was searched on the Cochrane Library, PubMed, Embase, and ScienceDirect databases for articles published from 1966 to February 2018. Secondary sources were identified from studies cited in the references. ... See full document
9
Forodesine in the treatment of relapsed/refractory peripheral T-cell lymphoma: an evidence-based review
... novel treatment option for the treatment of T-cell lymphomas for many years; forodesine finally achieved its first approval for relapsed/ refractory PTCL in ...for T-cell ... See full document
7
<p>Carvedilol vs endoscopic band ligation for the prevention of variceal bleeding: a meta-analysis</p>
... model was applied. Moreover, bleeding-related deaths were also assessed as an outcome measure to compare the safety of carvedilol use vs EBL intervention. The number of patients who died from bleeding in ... See full document
10
The Modified Glasgow Prognostic Scores as a Predictor in Diffuse Large B Cell Lymphoma Treated with R CHOP Regimen
... In conclusion, to our knowledge, we have demonstrated for the first time that mGPS can be considered a potential prognostic factor that may predict early responses to R- CHOP therapy in DLBCL patients. We also ... See full document
8
<p>PD-L1 and miR-34a are Prognostic Factors for Primary Gastric Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP</p>
... chemotherapy treatment of GDLBCL reduces the incidence of central ner- vous system ...programmed cell death 1 (PD-1) and its ligand (PD-L1) have a great prospect in the treatment of different ... See full document
10
Related subjects